LEXICON
No.148 June 29, 2015

Z2 Rule
Z2(ゼットツー)

The Ministry of Health, Labor and Welfare (MHLW) introduced the so-called “Z2” rule (Z2, ゼットツー; zetto tsu ) under the NHI pricing reform in April 2014 to speed up the shift from long-listed products (LLPs) (長期収載品; choki shusai hin )...

To read the full story

LEXICON

Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

By Yoshinori Sagehashi

Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…